Company Vademecum Srl with Fiscal Code 7811360
recorded a turnover of 2024 of
224.919,
with a net profit of
8.484
and having an average number of employees of
8.
The company operates in the field of Activităţi de asistenţă medicală specializată having the NACE code 8622.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Vademecum Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
130.209
114.502
130.938
180.262
199.537
216.805
227.897
182.224
196.162
224.919
Total Income - EUR
130.210
114.898
130.940
180.263
199.544
216.839
227.950
187.900
196.164
224.968
Total Expenses - EUR
127.397
109.140
116.381
148.035
179.791
213.443
220.700
145.438
175.470
210.207
Gross Profit/Loss - EUR
2.813
5.757
14.559
32.228
19.753
3.396
7.250
42.462
20.694
14.761
Net Profit/Loss - EUR
2.163
4.811
11.904
30.429
17.757
1.348
5.016
40.621
18.968
8.484
Employees
13
10
11
11
11
9
9
7
7
8
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
In the last year of activity, the sales increased by 15.3%, from 196.162 euro in the year 2023, to 224.919 euro in 2024.
The Net Profit decreased by -10.378 euro, from 18.968 euro in 2023, to 8.484 in the last year.
Check the financial reports for the company - Vademecum Srl
Financial Rating - VADEMECUM SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Vademecum Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Vademecum Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Vademecum Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
12.339 euro in 2024 which includes Inventories of
0 euro, Receivables of
10.553 euro and cash availability of
1.787 euro.
The company's Equity was valued at
48.020 euro, while total Liabilities amounted to
22.723 euro.
Equity decreased by -10.090 euro, from 58.437 euro in 2023, to 48.020 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Vademecum Srl